หน้าแรก
ค้นหา
Dr. Chung: Would you consider re-initiating bevacizumab in pts with multiple lines of treatment?
Dr. Chung discusses the treatment of a patient with metastatic colorectal cancer (mCRC).
แสดงข้อมูลเพิ่มเติม 1
Dr. Chung: Would you consider re-initiating bevacizumab in pts with multiple lines of treatment?
Dr. Dirk Arnold on Second-Line Bevacizumab Continuation Therapy for Metastatic Colorectal Cancer
Improving guidance on choice of first-line therapy for patients with HCC
mCRC: Considerations for Localized Therapy and Maintenance
Dr. Roth Discusses the Treatment of Several Cancers With Bevacizumab
Personal Experience with Bevacizumab
Maintenance Therapy for mCRC
Considering Maintenance Therapy in Metastatic Colorectal Cancer
Dr. McBride on the Potential Impact of Bevacizumab Biosimilars in Oncology
The Rationale for FOLFOX and Bevacizumab in mCRC
Maintenance Treatment in Colorectal Cancer
Treatment Options for Third-Line Therapy in mCRC
Maintenance Therapy in Colorectal Cancer
Later-Line Therapy Innovations in MCRC
Dr. Burris on Treatment Considerations in TNBC
Dr. Eng: How to Prolong Survival
Dr. Saltz Discusses Chemotherapy in Metastatic CRC
Avastin ( Bevacizumab ) Passion video
Bevacizumab nel carcinoma del colon-retto avanzato